Gluckstein Lawyers Launch Class-Action Lawsuit Against Manufacturer of Knee Implant Device

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Gluckstein Lawyers Launch Class-Action Lawsuit Against Manufacturer of Knee Implant Device

Canada NewsWire

TORONTO, Jan. 21, 2022 /CNW/ - Gluckstein Lawyers has commenced a proposed class-action personal injury lawsuit alleging a "shockingly high failure rate" of the DePuy Attune Total Knee Arthroplasty implant that "were defective and unreasonably dangerous- when sold."

The proposed class action is brought against DePuy Synthes Companies, Synthes (Canada), Depuy Orthopaedics Inc. and Johnson & Johnson on behalf of representative claimant Cassandra Lyon and thousands of patients who received the implant and have experienced a device failure. It is alleged that many suffered severe complications that necessitated additional surgeries one or two years after the device was implanted. 

The system is a total knee replacement implant manufactured by DePuy Synthes, a subsidiary of Johnson & Johnson, and was approved in the United States by the Food and Drug Administration in December 2010 under the agency's 510(k) clearance process. Devices approved through this process are not required to undergo clinical trials, nor do they require any evidence of safety before being approved and distributed for implantation. This process allows such medical devices to be available for faster treatment. However, it also increases the risk that a faulty device will be distributed without proper evaluation.

Between 2002 and 2013, DePuy Synthes recalled 277 knee replacement and related components due to implant loosening and premature failure. This was a Class I device recall, meaning that the product is linked to serious or even fatal adverse health consequences.

The Plaintiffs state that they had no way of knowing that the device used in their total knee replacement surgeries was defective in design, manufacture and marketing, even when properly implanted by surgeons and/or healthcare providers.

Typically, patients who receive a total knee replacement can expect the implanted joint to last approximately 20 years. However, the plaintiffs allege the DePuy system has been failing at a much faster rate for many patients, most within less than two years.

"Public trust in our healthcare system extends to the devices our medical professionals use. Ultimately, a catastrophic device failure erodes that confidence," says Class-action lawyer Jordan Assaraf of Gluckstein Lawyers. "A lawsuit offers consumer protection, allowing people who might not have the resources to take on these large organizations and corporations to seek justice." 

If you have experienced pain or complications from the DePuy Attune Knee Implant and would like further information about the lawsuit, please contact Gluckstein Lawyers at (416) 408-4252 or visit our website.

SOURCE Gluckstein Personal Injury Lawyers

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/January2022/21/c3509.html

Copyright CNW Group 2022

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).